Maximum quantity allowed is 999
请选择数量
CAS RN: 159857-80-4 | 產品號碼: M3224
MC-Val-Cit-PAB-OH
×
![]()
×
純度/分析方法: >98.0%(HPLC)(N)
别名:
- N-[6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanoyl]-L-valyl-N5-carbamoyl-N-[4-(hydroxymethyl)phenyl]-L-ornithinamide
- 6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-N-[(S)-1-[[(S)-1-[[4-(hydroxymethyl)phenyl]amino]-1-oxo-5-ureidopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]hexanamide
文件：
* 以上價格已含運費關稅等但一些需要海運以及乾冰運輸的產品除外,詳情請與
當地經銷商
洽詢。
* TCI會時常優化儲存條件,儲存溫度請以在線目錄為準，敬請留意。
產品規格
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(with Total Nitrogen) | min. 98.0 % |
性質
GHS
相關法規
運輸資料
| HS編碼* | 2925.19-000 |
Application
A Peptide Linker Designed for Antibody-Drug Conjugate (ADC)
This product is a peptide linker designed for Antibody-Drug Conjugate (ADC) which concept is to use an antibody to deliver a cytotoxic drug (payload) selectively to a target such as a tumor-associated antigen.
References
- Cathepsin B-Labile Dipeptide Linkers for Lysosomal Release of Doxorubicin from Internalizing Immunoconjugates: Model Studies of Enzymatic Drug Release and Antigen-Specific In Vitro Anticancer Activity
- Antibody-Drug Conjugates for Cancer Therapy
- Design, Synthesis, and Biological Evaluation of Antibody-Drug Conjugates Comprised of Potent Camptothecin Analogues
產品介紹報導
[Featured Products] Enzymatically Cleavable Linkers for Antibody-Drug Conjugates (ADCs)[TCIMAIL No.183] Dipeptides Degradable by Enzyme in Lysosome
產品文件 （部分產品的分析圖譜無法提供，敬請諒解。）
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助，請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注：該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉，您搜索的分析圖譜無法提供。